Volume 9, Issue 1 (2018)                   JMBS 2018, 9(1): 103-110 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohebbi S, Behmanesh M, Nikkhah M, Tohidi Moghadam T. Apoptosis Induction in Glioma Cells by Downregulation of HIF-1α Gene. JMBS 2018; 9 (1) :103-110
URL: http://biot.modares.ac.ir/article-22-24305-en.html
1- Nanobiotechnology‎ Department, Biological Sciences Faculty, Tarbiat Modares University, Tehran, Iran
2- Genetic & Nanobiotechnology‎ Department, Biological Sciences Faculty, Tarbiat Modares University, Tehran, Iran, Tarbiat Modares University, Nasr Bridge, Jalal-Al-Ahmad Highway, Tehran, Iran. , behmanesh@modares.ac.ir
3- Nanobiotechnology Department, Biological Sciences Faculty, Tarbiat Modares University, Tehran, Iran
Abstract:   (3714 Views)
Aims: HIF-1 transcription factor is a key determinant of oxygen-dependent gene regulation, which its role has been demonstrated for the survival and progress of cancer tumors. The effect of suppression of HIF-1α on the evaluation of HIF-1 dependent processes and interference with pathophysiological events caused by hypoxia is important. The aim of this study was the apoptosis induction in glioma cells by downregulation of Hif-1α gene.
Materials and Methods: In this experimental study, a specific siRNA against the HIF1α gene was developed using OligoWalk and Mit (siRNA.wi.mit.edu) servers and the online design department of Invivogene and Qiagene companies and the efficacy of its silencing in the U87 glioma cell line was quantitatively investigated by the Real-time PCR technique. In order to find out the effect of reduction of expression in the process of cell cycle and apoptosis, staining with PI and Annexin-PI was performed and the number of cells in each phase and the rate of cell mortality with control were compared by flow cytometry.
Findings: The designed HIF-1a-siRNA was able to reduce HIF1α expression by 40%. The treatment of U87 cells after 24 hours increased the cells by 6% and after 48 hours, increased them by 12% in the sub G1 stage. Confirming the cell cycle changes, 48-hour treatment induced apoptosis in 58% of cells; regarding the 1.5% rate of apoptosis in the control cells, this cell death rate was very significant and showed the ability of the designed siRNA to induce apoptosis.
Conclusion: The apoptosis induction of specific siRNA designed against HIF1α gene has a significant effect on the reduction of HIF-1α gene expression, cell growth, and apoptosis.
Full-Text [PDF 1155 kb]   (6205 Downloads)    
Subject: Agricultural Biotechnology
Received: 2018/05/16 | Accepted: 2017/02/5 | Published: 2018/03/20

1. Kushi LH, Doyle C, McCullough M, Rock CL, Demark-Wahnefried W, Bandera EV, et al. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012;62(1):30-67. [Link] [DOI:10.3322/caac.20140]
2. World Health Organization. Cancer Fact sheet N°297 [Internet]. Geneva: World Health Organization; 2014. [cited 2016 Sep 19?]. Available from: http://www.who.int/en/news-room/fact-sheets/detail/cancer. [Link]
3. National Cancer Institute. Defining Cancer [Internet]. Rockville: National Cancer Institute; 2014. [cited 2016 Sep 19]. Available from: https://www.cancer.gov/about-cancer/understanding/what-is-cancer. [Link]
4. Jain RK. Transport of molecules in the tumor interstitium: A review. Cancer Res. 1987;47(12):3039-305. [Link]
5. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science. 2001;292(5516):464-8. [Link] [DOI:10.1126/science.1059817]
6. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001;292(5546):468-72. [Link] [DOI:10.1126/science.1059796]
7. Lee W, Bae SH, Jeong JW, Kim SH, Kim KW. Hypoxia-inducible factor (HIF-1)α: Its protein stability and biological functions. Exp Mol Med. 2004;36(1):1-12. https://doi.org/10.2119/2004-00024.Lee [Link] [DOI:10.1038/emm.2004.1]
8. Harris AL. Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2(1):38-47. [Link] [DOI:10.1038/nrc704]
9. Tian H, McKnight SL, Russell DW. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 1997;11(1):72-82. [Link] [DOI:10.1101/gad.11.1.72]
10. Ema M, Taya Sh, Yokotani N, Sogawa K, Matsuda Y, Fujii-Kuriyama Y. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1 regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci U S A. 1997;94(9):4273-8. [Link] [DOI:10.1073/pnas.94.9.4273]
11. Gu YZ, Moran SM, Hogenesch JB, Wartman L, Bradfield CA. Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha. Gene Expr. 1998;7(3):205-13. [Link]
12. Holmquist-Mengelbier L, Fredlund E, Löfstedt T, Noguera R, Navarro S, Nilsson H, et al. Recruitment of HIF-1 and HIF-2 to common target genes isdifferentially regulated in neuroblastoma: HIF-2 promotes an aggressive phenotype. Cancer Cell. 2006;10(5):413-23. [Link] [DOI:10.1016/j.ccr.2006.08.026]
13. Baba Y, Nosho K, Shima K, Irahara N, Chan AT, Meyerhardt JA. HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. Am J Pathol. 2010;176(5):2292-301. [Link] [DOI:10.2353/ajpath.2010.090972]
14. Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM, et al. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res. 2000;60(15):4010-5. [Link]
15. Vaupel P. The role of hypoxia-induced factors in tumor progression. Oncologist. 2004;9(Suppl 5):10-7. [Link] [DOI:10.1634/theoncologist.9-90005-10]
16. Ziello JE, Jovin IS, Huang Y. Hypoxia-inducible factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in Malignancy and Ischemia. Yale J Biol Med. 2007;80(2):51-60. [Link]
17. Koh MY, Spivak-Kroizman TR, Powis G. HIF-1alpha and cancer therapy. Recent Results Cancer Res. 2010;180:15-34. [Link] [DOI:10.1007/978-3-540-78281-0_3]
18. Hopkins AL, Groom CR. The druggable genome. Nat Rev Drug Discov. 2002;1(9):727-30. [Link] [DOI:10.1038/nrd892]
19. Leung RK, Whittaker PA. RNA interference: From gene silencing to gene-specific therapeutics. Pharmacol Ther. 2005;107(2):222-39. [Link] [DOI:10.1016/j.pharmthera.2005.03.004]
20. Couzin J. Breakthrough of the year, Small RNAs make big splash. Science. 2002;298(5602):2296-7. [Link] [DOI:10.1126/science.298.5602.2296]
21. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature. 2001;409(6818):363-6. [Link] [DOI:10.1038/35053110]
22. Farsani ZSh, Behmanesh M, Sahraian MA. Interleukin-10 but not transforming growth factor-β1 gene expression is up-regulated by vitamin D treatment in multiple sclerosis patients. J Neurol Sci. 2015;350(1-2):18-23. [Link] [DOI:10.1016/j.jns.2015.01.030]
23. Rapisarda A, Uranchimeg B, Scudiero DA, Selby M, Sausville EA, Shoemaker RH, et al. Identification of small molecule inhibitors of hypoxia-inducible factor-1 transcriptional activation pathway. Cancer Res. 62(15):4316-24. [Link]
24. Sun X, Kanwar JR, Leung E, Lehnert K, Wang D, Krissansen GW. Gene transfer of antisense hypoxia-inducible factor-1a enhances the therapeutic efficacy of cancer immunotherapy. Gene Ther. 2001;8(8):638-45. [Link] [DOI:10.1038/sj.gt.3301388]
25. Hänze J, Eul BG, Savai R, Krick S, Goyal P, Grimminger F. RNA interference for HIF-1a inhibits its downstream signaling and affects cellular proliferation. Biochem Biophys Res Commun. 2003;312(3):571-7. [Link] [DOI:10.1016/j.bbrc.2003.10.153]
26. Green SL, Freiberg RA, Giaccia AJ. p21(Cip1) and p27(Kip1)regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest. Mol Cell Biol. 2001;21(4):1196-206. [Link] [DOI:10.1128/MCB.21.4.1196-1206.2001]
27. Flamant L, Notte A, Ninane N, Raes M, Michieles C. Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia. Mol Cancer. 2010;9:191. [Link] [DOI:10.1186/1476-4598-9-191]
28. Khan MN, Bhattacharyya T, Andrikopoulos P, Esteban MA, Barod R, Connor T. Factor inhibiting HIF (FIH-1) promotes renal cancer cell survival by protecting cells from HIF-1alpha-mediated apoptosis. Br J Cancer. 2011;104(7):1151-9. [Link] [DOI:10.1038/bjc.2011.73]
29. Kajstura M, Halicka HD, Pryjma J, Darzynkiewicz Z. Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete "sub-G1" peaks on DNA content histograms. Cytometry A. 2007;71(3):125-31. [Link] [DOI:10.1002/cyto.a.20357]
30. Gardner LB, Li Q, Park MS, Flanagan WM, Semenza GL, Dang CV. Hypoxia inhibits G1/S transition through regulation of p27 expression. J Biol Chem. 2001;276(11):7919-26. [Link] [DOI:10.1074/jbc.M010189200]
31. Wang Y. Pakunlu RI, Tsao W, Pozharov V, Minko T. Bimodal effect of hypoxia in cancer: Role of hypoxia inducible factor in apoptosis. Mol Pharm. 2004;1(2):156-65. [Link] [DOI:10.1021/mp034031n]
32. Chen Ch, Yu Z. siRNA targeting HIF-1alpha induces apoptosis of pancreatic cancer cells through NF-kappa B independent and -dependent pathways under hypoxic conditions. Anticancer Res. 2009;29(4):1367-72. [Link]
33. Hammond EM, Giaccia AJ. The role of p53 in hypoxia induced apoptosis. Biochem Biophys Res Commun. 2005;331(3):718-25. [Link] [DOI:10.1016/j.bbrc.2005.03.154]
34. Zhang X, Kon T, Wang H, Li F, Huang Q, Rabbani ZN, et al. Enhancement of hypoxia-induced tumor cell death in vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor-1 alpha. Cancer Res. 2004;64(22):8139-42. [Link] [DOI:10.1158/0008-5472.CAN-03-2301]
35. Welsh S, Williams R, Kirkpatrick L, Paine-Murrieta G, Powis G. Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha. Mol Cancer Ther. 2004;3(3):233-44. [Link]
36. Wu XA, Sun Y, Fan QX, Wang LX, Wang RL, Zhang L. Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia. Zhonghua Yi Xue Za Zhi. 2007;87(37):2640-4. [Chinese] [Link]
37. Kimura S, Kitadai Y, Tanaka S, Kuwai T, Hihara J, Yoshida K, et al. Expression of hypoxia-inducible factor (HIF)-1alpha is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma. Eur J Cancer. 2004;40(12):1904-12. [Link] [DOI:10.1016/j.ejca.2004.04.035]
38. Kurokawa T, Miyamoto M, Kato K, Cho Y, Kawarada Y, Hida Y, et al. Overexpression of hypoxia-inducible-factor 1alpha(HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Br J Cancer. 2003;89(6):1042-7. [Link] [DOI:10.1038/sj.bjc.6601186]
39. Seeber LM, Zweemer RP, Verheijen RH, van Diest PJ. Hypoxiainducible factor-1 as a therapeutic target in endometrial cancer management. Obstet Gynecol Int. 2010;2010:580971. [Link]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.